Antigenics' Other Investors

Antigenics raised a round of funding on , . Investors include BCM Technologies.

Antigenics (NASDAQ: AGEN) is a biotechnology company working to develop treatments for cancers and infectious diseases.…

Articles about Antigenics' Other Investors: